EX-FILING FEES 4 ea022157701ex-fee_neuro.htm FILING FEE TABLE

Exhibit 107

 

Calculation of Filing Fee Table

 

Form F-1

(Form Type)

 

NeuroSense Therapeutics Ltd.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

Security
Type

 

Security
Class Title

 

Fee
Calculation
Rule

  

Amount
Registered(1)

  

Proposed
Maximum
Offering
Price Per
Share(2)(3)

  

Maximum
Aggregate
Offering Price

   Fee Rate  

Amount of
Registration
Fee

 
Equity  Ordinary shares, no par value, per share   457(c)   10,000,000(4)   $1.235   $12,350,000    0.0001531   $1,890.79 
Total Offering Amount    10,000,000        $12,350,000        $1,890.79 
Total Fees Previously Paid                        — 
Total Fee Offsets                        — 
Net Fee Due                       $1,890.79 

 

(1) Pursuant to Rule 416(a) under the U.S. Securities Act of 1933, as amended (the “Securities Act”), the securities being registered hereunder also include such indeterminable number of additional securities as may from time to time be issued after the date hereof as a result of stock splits, stock dividends, recapitalizations or similar transactions.
   
(2) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(c) under the Securities Act and based upon the average of the high and low sale prices of the Registrant’s ordinary shares on the Nasdaq Capital Market on November 15, 2024, which was $1.235.
   
(3) The Registrant will not receive any proceeds from the sale of its ordinary shares by the selling shareholder.
   
(4) All of the ordinary shares are to be offered for resale by the selling shareholder named in the prospectus contained in this Registration Statement on Form F-1